Skip to main content
Contact Us
Subscribe
E-Edition
75°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc. Common Stock
(NY:
BHC
)
4.540
-0.160 (-3.40%)
Streaming Delayed Price
Updated: 3:44 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
May 06, 2025
Via
ACCESS Newswire
Bausch Health Announces First Quarter 2025 Results
April 30, 2025
Via
ACCESS Newswire
Earnings Scheduled For April 30, 2025
April 30, 2025
Via
Benzinga
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
April 29, 2025
Via
ACCESS Newswire
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
April 25, 2025
Via
ACCESS Newswire
Bausch Health Says Carl Icahn Has 34% Economic Interest In Its Outstanding Shares
April 22, 2025
This disclosure comes days after the company announced a new “poison pill” plan to safeguard shareholders’ rights and prevent hostile takeovers.
Via
Stocktwits
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
February 19, 2025
Via
ACCESS Newswire
Earnings Scheduled For February 19, 2025
February 19, 2025
Via
Benzinga
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
February 10, 2025
Via
ACCESS Newswire
Bausch Health Announces Filing of Supplement to Proxy Statement
April 22, 2025
Via
ACCESS Newswire
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
April 17, 2025
Via
ACCESS Newswire
Bausch Health Announces Adoption of Shareholder Rights Plan
April 14, 2025
Via
ACCESS Newswire
Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program
April 10, 2025
Via
ACCESS Newswire
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
April 02, 2025
Via
ACCESS Newswire
Bausch Health to Announce First Quarter Results on April 30
March 27, 2025
Via
ACCESS Newswire
Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 26, 2025
Via
Benzinga
Bausch Health Announces Pricing of Upsized Private Offering of Senior Secured Notes
March 25, 2025
Via
ACCESS Newswire
Bausch Health Announces Conditional Redemption of Senior Notes
March 21, 2025
Via
ACCESS Newswire
Bausch Health Announces Launch of Syndication of New Senior Secured Credit Facilities
March 19, 2025
Via
ACCESS Newswire
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
March 19, 2025
Via
ACCESS Newswire
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
March 18, 2025
Via
Benzinga
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
March 14, 2025
Via
ACCESS Newswire
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday
February 20, 2025
Via
Benzinga
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises
February 19, 2025
The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China.
Via
Stocktwits
Topics
Earnings
Exposures
Financial
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance
February 19, 2025
Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report:
Via
Benzinga
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
February 14, 2025
Via
ACCESS Newswire
Bausch Health Provides Update on Strategic Alternatives
February 06, 2025
Via
ACCESS Newswire
Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 03, 2025
Via
Benzinga
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
January 23, 2025
Via
ACCESS Newswire
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
January 17, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.